Search Tag: recurrence prediction
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 11 Oct
Anticipating postoperative outcomes in oesophageal squamous cell carcinoma (ESCC) remains difficult given frequent relapse and poor prognosis after recurrence. Contrast-enhanced CT contains quantitative information beyond routine visual assessment. By extracting radiomic features from preoperative CT and combining them with clinicopathological...Read more
2025 16 Aug
Colorectal cancer is among the most common gastrointestinal malignancies and is the third leading cause of cancer-related mortality worldwide. Stage II disease is characterised by tumours that have not yet spread to lymph nodes or distant organs. Surgery is the primary treatment, yet recurrence occurs in 20–25% of patients after resection, often...Read more
2025 09 Jun
Locally advanced rectal cancer (LARC) continues to present challenges in treatment due to the high variability in patient outcomes following standard protocols. While total mesorectal excision combined with neoadjuvant chemoradiotherapy (nCRT) has improved local control, recurrence or metastasis remains common. Identifying patients at high risk...Read more